Compare GSK plc (GSK) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? GSK plc trades at $50.3 (market cap $101.13B), while Invesco S&P 500 High Div Low Volatility ETF trades at $53.67. The key difference: GSK plc pays a 3.61% dividend while Invesco S&P 500 High Div Low Volatility ETF pays none, and Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, GSK plc nearer its low. Which is the better fit depends on your goals.
| GSK | SPHD | |
|---|---|---|
Market Cap | $101.13B | — |
Sector | Health | — |
52-Week High | $61.18 | $53.55 |
52-Week Low | $38.96 | $46.96 |
Enterprise Value | $121.57B | — |
Dividend Yield | 3.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.45, down 0.88% today, with a bearish technical signal from moving averages. The company has delivered three consecutive quarterly earnings beats, with Q2 2026 EPS of $1.36 exceeding expectations. Revenue growth remains steady at 5% constant currency, supported by strong vaccine and specialty medicine performance. Recent FDA approval for Jideytro in lung cancer and a $2.52 billion cost-saving initiative signal strategic focus on pipeline acceleration.
GSK presents a mixed outlook with strong fundamentals but technical headwinds. The company's 29.73% ROE and 14.52% net margin demonstrate operational efficiency, while the 15.8 P/E offers reasonable valuation. However, bearish technical indicators and cautious analyst sentiment (55% hold rating) suggest near-term consolidation. Key risks include pipeline execution and regulatory pressures, but the dividend yield and cost-saving program provide stability.
SPHD trades at $52.47, down slightly by 0.06% today, with a bullish technical signal from moving averages and neutral oscillators. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering a 4.4% yield as of July 2026 (24/7 Wall Street, 2026-07-22). Recent dividend payments of $0.21 per share highlight its income appeal amid market volatility, with inflows favoring dividend strategies in July (ETF Trends, 2026-08-04).
The outlook is positive for income seekers, with low volatility providing cushion during market swings, but risks include interest rate sensitivity and competition from other income ETFs. Analyst sentiment is neutral to bullish, emphasizing stability in uncertain times.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
